This proposal aims at using chemical synthesis to prepare four classes of anticancer natural products with great potential that have eluded study due to their scarcity in nature and the fact that no solution for their chemical synthesis exists. Practical syntheses of vinigrol, maoecrystal, kapakahine, sarcodonin, and related family members will require the development of new synthetic methodologies, as well as the exploration of novel chemical entities and reactivity patterns. In addition, a thorough exploration of their biology through the synthesis of carefully designed analogs is planned. Each of these natural product families represent ideal targets from both a chemical and biological perspective. Chemically, they challenge the state of the art and require innovative solutions in order to accomplish their practical total synthesis. They elicit their biological influence through as yet unknown mechanisms and thus have the potential to shed light on fundamental biochemical processes. Finally, they are endowed with potent bioactivity and could conceivably enter into a clinical setting. New strategies and methods in chemistry and substantial contributions to medicine are anticipated through strategic collaborations with several leaders in the field of cancer biology.

Public Health Relevance

This proposal aims at using chemical synthesis to prepare four classes of anti-cancer natural products with great potential in cancer therapy. Innovations in chemistry are anticipated and substantial contributions to medicine will result through strategic collaborations with several leaders in the field of cancer biology.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BCMB-B (02))
Program Officer
Lees, Robert G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Renata, Hans; Zhou, Qianghui; Dünstl, Georg et al. (2015) Development of a concise synthesis of ouabagenin and hydroxylated corticosteroid analogues. J Am Chem Soc 137:1330-40
Renata, Hans; Zhou, Qianghui; Baran, Phil S (2013) Strategic redox relay enables a scalable synthesis of ouabagenin, a bioactive cardenolide. Science 339:59-63
Usui, Ippei; Lin, David W; Masuda, Takeshi et al. (2013) Convergent synthesis and structural confirmation of phellodonin and sarcodonin ?. Org Lett 15:2080-3
Voica, Ana-Florina; Mendoza, Abraham; Gutekunst, Will R et al. (2012) Guided desaturation of unactivated aliphatics. Nat Chem 4:629-35
Köck, Matthias; Schmidt, Gesine; Seiple, Ian B et al. (2012) Configurational analysis of tetracyclic dimeric pyrrole-imidazole alkaloids using a floating chirality approach. J Nat Prod 75:127-30
Mendoza, Abraham; Ishihara, Yoshihiro; Baran, Phil S (2012) Scalable enantioselective total synthesis of taxanes. Nat Chem 4:21-5
Cherney, Emily C; Baran, Phil S (2011) Terpenoid-Alkaloids: Their Biosynthetic Twist of Fate and Total Synthesis. Isr J Chem 51:391-405
Lin, David W; Masuda, Takeshi; Biskup, Moritz B et al. (2011) Synthesis-guided structure revision of the sarcodonin, sarcoviolin, and hydnellin natural product family. J Org Chem 76:1013-30
Shi, Jun; Manolikakes, Georg; Yeh, Chien-Hung et al. (2011) Scalable synthesis of cortistatin A and related structures. J Am Chem Soc 133:8014-27
Newhouse, Timothy; Baran, Phil S (2011) If C-H bonds could talk: selective C-H bond oxidation. Angew Chem Int Ed Engl 50:3362-74

Showing the most recent 10 out of 25 publications